The TNF pathway contributes to not only the cancer-promoting inflammation of PC cells but also to their metastasis, immune surveillance, treatment resistant capacity, and angiogenic activities, and its expression and activation profiles are related to the risk of cancer induction, prognosis, metastasis, and cancer severity in patients with PC [122–126]. This evidence concerns the gene TNF and pachyonychia congenita.